{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:42:53Z","timestamp":1789562573443,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24591382"],"award-info":[{"award-number":["24591382"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26461415"],"award-info":[{"award-number":["26461415"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["18013021"],"award-info":[{"award-number":["18013021"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","award":["22112007"],"award-info":[{"award-number":["22112007"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health and Labour Sciences Research Grants","award":["24 008"],"award-info":[{"award-number":["24 008"]}]},{"name":"Mitsubishi Pharma Research Foundation"},{"name":"Naito Grant"},{"DOI":"10.13039\/100004416","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.addr.2015.11.010","type":"journal-article","created":{"date-parts":[[2015,11,15]],"date-time":"2015-11-15T03:43:23Z","timestamp":1447559003000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"PB","title":["Cancer therapy targeting the fibrinolytic system"],"prefix":"10.1016","volume":"99","author":[{"given":"Beate","family":"Heissig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salita","family":"Eiamboonsert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douaa","family":"Dhahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2015.11.010_bb0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1042\/BST0330331","article-title":"A genomic view of the complexity of mammalian proteolytic systems","volume":"33","author":"Puente","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.addr.2015.11.010_bb0010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1084\/jem.20050959","article-title":"Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization","volume":"202","author":"Heissig","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.11.010_bb0015","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1128\/iai.64.10.4307-4312.1996","article-title":"Borrelia burgdorferi induces secretion of pro-urokinase-type plasminogen activator by human monocytes","volume":"64","author":"Fuchs","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.11.010_bb0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.addr.2015.11.010_bb0025","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1182\/blood-2011-03-344242","article-title":"Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT","volume":"118","author":"Lighvani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0030","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.3390\/ijms14036259","article-title":"Annexin A2 heterotetramer: structure and function","volume":"14","author":"Bharadwaj","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2015.11.010_bb0035","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1074\/jbc.M111219200","article-title":"Identification of annexin II heterotetramer as a plasmin reductase","volume":"277","author":"Kwon","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.11.010_bb0040","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/bi00268a014","article-title":"Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody","volume":"21","author":"Nielsen","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2015.11.010_bb0045","doi-asserted-by":"crossref","first-page":"597927","DOI":"10.1155\/2013\/597927","article-title":"Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer","volume":"2013","author":"Santibanez","year":"2013","journal-title":"ISRN Dermatol."},{"key":"10.1016\/j.addr.2015.11.010_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid\u2014an old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.addr.2015.11.010_bb0055","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2015.11.010_bb0060","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0960-894X(00)00431-5","article-title":"Development of plasmin and plasma kallikrein selective inhibitors and their effect on M1 (melanoma) and HT29 cell lines","volume":"10","author":"Okada","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2015.11.010_bb0065","first-page":"281","article-title":"A novel plasmin-inhibitor inhibits the growth of human tumor xenografts and decreases metastasis number","volume":"16","author":"Szende","year":"2002","journal-title":"In Vivo"},{"key":"10.1016\/j.addr.2015.11.010_bb0070","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/leu.2011.203","article-title":"Plasmin inhibitor reduces T-cell lymphoid tumor growth by suppressing matrix metalloproteinase-9-dependent CD11b(+)\/F4\/80(+) myeloid cell recruitment","volume":"26","author":"Ishihara","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2015.11.010_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/leu.2014.151","article-title":"Inhibition of plasmin attenuates murine acute graft-versus-host disease mortality by suppressing the matrix metalloproteinase-9-dependent inflammatory cytokine storm and effector cell trafficking","volume":"29","author":"Sato","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.addr.2015.11.010_bb0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1053\/j.gastro.2014.12.001","article-title":"Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells","volume":"148","author":"Munakata","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2015.11.010_bb0085","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: a dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/physrev.1993.73.1.161","article-title":"Biology and biochemistry of proteinases in tumor invasion","volume":"73","author":"Mignatti","year":"1993","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2015.11.010_bb0095","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1160\/TH05-01-0054","article-title":"Plasminogen activation and cancer","volume":"93","author":"Dano","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.addr.2015.11.010_bb0100","first-page":"841","article-title":"Content and characterization of plasminogen activators in human lung tumors and normal lung tissue","volume":"40","author":"Markus","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2015.11.010_bb0105","first-page":"345","article-title":"Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification","volume":"65","author":"Corasanti","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.addr.2015.11.010_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/94.2.116","article-title":"Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients","volume":"94","author":"Look","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.addr.2015.11.010_bb0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1684\/bdc.2010.1047","article-title":"UPA\/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays","volume":"97","author":"Lamy","year":"2010","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.addr.2015.11.010_bb0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0092-8674(00)80429-8","article-title":"ECM and cell surface proteolysis: regulating cellular ecology","volume":"91","author":"Werb","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ng1297-439","article-title":"Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation","volume":"17","author":"Carmeliet","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.addr.2015.11.010_bb0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.stem.2007.10.012","article-title":"The plasminogen fibrinolytic pathway is required for hematopoietic regeneration","volume":"1","author":"Heissig","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0135","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1055\/s-0037-1615036","article-title":"Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen\/plasmin system","volume":"79","author":"Lijnen","year":"1998","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.addr.2015.11.010_bb0140","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V91.6.2045","article-title":"Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice","volume":"91","author":"Lijnen","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0167-4838(01)00186-8","article-title":"Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1","volume":"1547","author":"Lijnen","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2015.11.010_bb0150","first-page":"329","article-title":"Hematological paraneoplastic syndromes","volume":"24","author":"Staszewski","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.addr.2015.11.010_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.11.010_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.20631","article-title":"Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice","volume":"113","author":"Almholt","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2015.11.010_bb0170","first-page":"22","article-title":"Plasmin therapy enhances mobilization of HPCs after G-CSF","volume":"22","author":"Tjwa","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0175","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/ATVBAHA.111.229583","article-title":"Plasminogen regulates stromal cell-derived factor-1\/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9","volume":"31","author":"Gong","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0180","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0092-8674(02)00754-7","article-title":"Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand","volume":"109","author":"Heissig","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0185","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.0212056","article-title":"Plasmin as a proinflammatory cell activator","author":"Syrovets","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0190","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-\u03baB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappa B system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2015.11.010_bb0200","first-page":"30","article-title":"Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms","volume":"3","author":"Lin","year":"2014","journal-title":"Am. J. Clin. Exp. Immunol."},{"key":"10.1016\/j.addr.2015.11.010_bb0205","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","article-title":"The two NF-\u03baB activation pathways and their role in innate and adaptive immunity","volume":"25","author":"Bonizzi","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2015.11.010_bb0210","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V97.12.3941","article-title":"Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK\u03b2-mediated NF-\u03baB activation","volume":"97","author":"Syrovets","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2005.12.188","article-title":"Potentiation of TLR4 signalling by plasmin activity","volume":"341","author":"Ward","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2015.11.010_bb0220","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/ATVBAHA.107.142901","article-title":"Plasmin triggers cytokine induction in human monocyte-derived macrophages","volume":"27","author":"Li","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0225","doi-asserted-by":"crossref","first-page":"33509","DOI":"10.1074\/jbc.M201941200","article-title":"The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)\/STAT signaling pathways","volume":"277","author":"Burysek","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.11.010_bb0230","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2353\/ajpath.2007.070472","article-title":"Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation","volume":"171","author":"Zhang","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2015.11.010_bb0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2015.11.010_bb0240","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood-2009-08-236851","article-title":"Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration","volume":"115","author":"Ohki","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0245","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1182\/blood-2011-12-399659","article-title":"Inhibition of PAI-1 induces neutrophil-driven neoangiogenesis and promotes tissue regeneration via production of angiocrine factors in mice","volume":"119","author":"Tashiro","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0250","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1172\/JCI32750","article-title":"Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice","volume":"118","author":"Gong","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2015.11.010_bb0255","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood-2007-12-129080","article-title":"Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx","volume":"112","author":"Dean","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0260","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.11.010_bb0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/jcp.21897","article-title":"Contribution of the fibrinolytic pathway to hematopoietic regeneration","volume":"221","author":"Heissig","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2015.11.010_bb0270","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrm2120","article-title":"In search of partners: linking extracellular proteases to substrates","volume":"8","author":"Overall","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0275","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1699-0463.1999.tb01529.x","article-title":"Proteolytic control of growth factor availability","volume":"107","author":"Rifkin","year":"1999","journal-title":"APMIS"},{"key":"10.1016\/j.addr.2015.11.010_bb0280","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1038\/sj.emboj.7600397","article-title":"Tissue plasminogen activator is a potent activator of PDGF-CC","volume":"23","author":"Fredriksson","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2015.11.010_bb0285","doi-asserted-by":"crossref","first-page":"34441","DOI":"10.1074\/jbc.M501903200","article-title":"Plasmin- and thrombin-accelerated shedding of Syndecan-4 ectodomain generates cleavage sites at Lys114\u2013Arg115 and Lys129\u2013Val130 bonds","volume":"280","author":"Schmidt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.11.010_bb0290","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2003-08-2708","article-title":"A critical role for CCR2\/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation","volume":"103","author":"Hildebrandt","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0295","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1172\/JCI38308","article-title":"An adventitial IL-6\/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice","volume":"119","author":"Tieu","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2015.11.010_bb0300","doi-asserted-by":"crossref","first-page":"31509","DOI":"10.1074\/jbc.M110.124891","article-title":"The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency","volume":"285","author":"Yao","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.11.010_bb0305","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1523\/JNEUROSCI.4987-06.2007","article-title":"Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice","volume":"27","author":"Sheehan","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addr.2015.11.010_bb0310","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.11.010_bb0315","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1593\/neo.07871","article-title":"Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response","volume":"10","author":"Pahler","year":"2008","journal-title":"Neoplasia (New York, N.Y.)"},{"key":"10.1016\/j.addr.2015.11.010_bb0320","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/ijc.24378","article-title":"Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression","volume":"125","author":"Fujimoto","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2015.11.010_bb0325","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.jid.5700827","article-title":"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft","volume":"127","author":"Gazzaniga","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2015.11.010_bb0330","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.addr.2015.11.010_bb0335","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1172\/JCI60588","article-title":"Cxcr2 and Cxcl5 regulate the IL-17\/G-CSF axis and neutrophil homeostasis in mice","volume":"122","author":"Mei","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2015.11.010_bb0340","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4049\/jimmunol.1202286","article-title":"In vivo processing of CXCL5 (LIX) by matrix metalloproteinase (MMP)-2 and MMP-9 promotes early neutrophil recruitment in IL-1beta-induced peritonitis","volume":"190","author":"Song","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.11.010_bb0345","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.ejca.2011.11.032","article-title":"CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer","volume":"48","author":"Kawamura","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.addr.2015.11.010_bb0350","doi-asserted-by":"crossref","first-page":"e51848","DOI":"10.1371\/journal.pone.0051848","article-title":"Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice","volume":"7","author":"Shang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2015.11.010_bb0355","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1158\/0008-5472.CAN-09-1451","article-title":"Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice","volume":"69","author":"Popivanova","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2015.11.010_bb0360","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood-2010-01-264754","article-title":"S100A10 regulates plasminogen-dependent macrophage invasion","volume":"116","author":"Connell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0365","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.1158\/0008-5472.CAN-11-1748","article-title":"Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites","volume":"71","author":"Phipps","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2015.11.010_bb0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.11.010_bb0375","first-page":"393","article-title":"A heparin-binding angiogenic protein\u2013basic fibroblast growth factor\u2013is stored within basement membrane","volume":"130","author":"Folkman","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2015.11.010_bb0380","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.106.5.1659","article-title":"Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium","volume":"106","author":"Lyons","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2015.11.010_bb0385","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12185-012-1016-y","article-title":"New functions of the fibrinolytic system in bone marrow cell-derived angiogenesis","volume":"95","author":"Heissig","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.addr.2015.11.010_bb0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jcp.1041610118","article-title":"Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF","volume":"161","author":"Gualandris","year":"1994","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2015.11.010_bb0395","first-page":"519","article-title":"A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor","volume":"67","author":"Passaniti","year":"1992","journal-title":"Lab. Investig."},{"key":"10.1016\/j.addr.2015.11.010_bb0400","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0405","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1091\/mbc.4.12.1317","article-title":"The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF","volume":"4","author":"Park","year":"1993","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0410","first-page":"1920","article-title":"Fibrinogen influx and accumulation of cross-linked fibrin in mouse carcinomas","volume":"48","author":"Brown","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2015.11.010_bb0415","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1016\/S0021-9258(18)35712-0","article-title":"Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms","volume":"267","author":"Houck","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.11.010_bb0420","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/med.21308","article-title":"Involvement of urokinase-type plasminogen activator system in cancer: an overview","volume":"34","author":"Mekkawy","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.addr.2015.11.010_bb0425","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrc2791","article-title":"Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors","volume":"10","author":"Butler","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2015.11.010_bb0430","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.11.010_bb0435","series-title":"Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation","author":"Schmid","year":"2010"},{"key":"10.1016\/j.addr.2015.11.010_bb0440","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00262-005-0048-z","article-title":"Role of immature myeloid cells in mechanisms of immune evasion in cancer","volume":"55","author":"Kusmartsev","year":"2006","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.addr.2015.11.010_bb0445","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.193.9.1005","article-title":"Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells","volume":"193","author":"Hattori","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.11.010_bb0450","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nm740","article-title":"Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment","volume":"8","author":"Hattori","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2015.11.010_bb0455","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0460","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.1074\/jbc.M114.599688","article-title":"Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90RSK and p38 MAPK pathway","volume":"290","author":"Lin","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.11.010_bb0465","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis","volume":"114","author":"Giraudo","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2015.11.010_bb0470","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2003-01-0190","article-title":"Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB\/c mice suppresses immune reactivity","volume":"102","author":"Melani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2015.11.010_bb0475","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2353\/ajpath.2009.080661","article-title":"The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain","volume":"174","author":"Zhang","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2015.11.010_bb0480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1681\/ASN.2005010089","article-title":"Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury","volume":"17","author":"Roelofs","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2015.11.010_bb0485","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1681\/ASN.2011111123","article-title":"Tissue plasminogen activator activates NF-kappaB through a pathway involving Annexin A2\/CD11b and integrin-linked kinase","volume":"23","author":"Lin","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.addr.2015.11.010_bb0490","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e3282f97d98","article-title":"Fibroblast growth factor regulation of neovascularization","volume":"15","author":"Murakami","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.addr.2015.11.010_bb0495","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2008.06.010","article-title":"The plasminogen fibrinolytic pathway is required for hematopoietic regeneration","volume":"3","author":"Heissig","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2015.11.010_bb0500","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/nature06348","article-title":"Bv8 regulates myeloid-cell-dependent tumour angiogenesis","volume":"450","author":"Shojaei","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.11.010_bb0505","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/1078-0432.CCR-11-0659","article-title":"Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis","volume":"17","author":"Lieu","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2015.11.010_bb0510","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat. Med."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15002744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15002744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T14:05:49Z","timestamp":1656252349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X15002744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":102,"alternative-id":["S0169409X15002744"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2015.11.010","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer therapy targeting the fibrinolytic system","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2015.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}